MeSH tree: D12.125.070
Monash University scientists have identified a less stringent and more manageable alternative to traditional intermittent fasting, offering new possibilities for extending lifespan and promoting healthy aging.
Feb 2, 2024
0
180
Although past research has indicated that moderate alcohol consumption can lower one's risk of cardiovascular disease (CVD), more recent studies suggest that moderate levels of drinking may be hazardous to heart health. A ...
Nov 27, 2023
0
52
There's a popular saying in some circles that "a calorie is a calorie," but science shows that it may not be true. In fact, it may be possible to eat more of some kinds of calories while also improving your health.
Nov 22, 2023
0
125
Fresh insights into the genes that cause the neurological disorder could open new routes for the prevention and perhaps even reversal of symptoms.
Jul 31, 2023
0
221
You might not think of diabetes when you think of muscle function. But a common diabetes drug that regulates blood sugar can also prevent muscle atrophy and muscular fibrosis—which can help the elderly bounce back faster ...
Jul 25, 2023
0
75
Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone after stabilization for worsening heart failure in patients with an ejection fraction (EF) above 40%, according to late ...
May 21, 2023
0
39
An analysis of global usage patterns of a common hypertension drug following a major recall demonstrates the worldwide impact of contamination at a single manufacturing facility.
Apr 17, 2023
0
55
A new research paper titled "Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis" has been published in Oncotarget.
Dec 1, 2022
0
41
A decrease in protein synthesis in the cells of the developing gut contributes to a rare genetic disorder, and an inexpensive nutritional supplement may help reverse that decrease, according to a new study by Yun-Fei Li of ...
Nov 1, 2022
1
820
Swiss pharmaceuticals company Novartis said Thursday that it plans to spin off its generics subsidiary Sandoz, which generated nearly $10 billion in revenue last year.
Aug 25, 2022
0
36
